EVOK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 mai 2024 @ 22:00):

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases...

Stats
Dagens volum	46 862.00
Gjennomsnittsvolum	30 588.00
Markedsverdi	3.88M
EPS	$0 ( 2024-05-20 )
Neste inntjeningsdato	( $-0.0600 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.190
ATR14	$0.00600 (1.33%)

Insider Trading

Date	Person	Action	Amount	type
2023-05-10	Widder Kenneth J	Buy	14 250	Stock Option (Right to Buy)
2023-05-10	Reed Vickie S	Buy	15 000	Stock Option (Right to Buy)
2023-05-10	Hill Malcolm R	Buy	14 625	Stock Option (Right to Buy)
2023-05-10	Garner Cam L	Buy	17 750	Stock Option (Right to Buy)
2023-05-10	Brady Todd C	Buy	14 625	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 99 transactions
Buy: 6 847 814 \| Sell: 1 253 905

Evoke Pharma Inc Korrelasjon

10 Mest positive korrelasjoner
AEHR	0.957
VVOS	0.956
INVZ	0.945
EHTH	0.94
WW	0.94
OPEN	0.939
AVXL	0.934
NWFL	0.932
PACB	0.931
VUZI	0.929

10 Mest negative korrelasjoner
NESR	-0.931
BSCO	-0.916
INBKZ	-0.908
OXSQ	-0.899
ESTA	-0.891
ADTH	-0.889
DXJS	-0.888
APXI	-0.887
KRUS	-0.878
SWAV	-0.877

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Evoke Pharma Inc Økonomi

Annual	2023
Omsetning:	$5.18M
Bruttogevinst:	$4.98M (96.10 %)
EPS:	$-2.33

FY	2023
Omsetning:	$5.18M
Bruttogevinst:	$4.98M (96.10 %)
EPS:	$-2.33

FY	2022
Omsetning:	$2.51M
Bruttogevinst:	$2.14M (85.24 %)
EPS:	$-2.60

FY	2021
Omsetning:	$1.62M
Bruttogevinst:	$1.29M (79.72 %)
EPS:	$-3.24

Financial Reports:

No articles found.

Evoke Pharma Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Evoke Pharma Inc

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.